Publikationen, an denen er mitarbeitet David Pozo Pérez (3)

2018

  1. Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

    PLoS ONE, Vol. 13, Núm. 5

  2. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus

    Nature Communications, Vol. 9, Núm. 1

2013

  1. Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation

    PLoS ONE, Vol. 8, Núm. 11